Preparation method of a core-shell structure drug carrier for near-infrared light-excited supramolecular valve light-controlled drug release
A technology of core-shell structure and near-infrared light, which is applied to the photodissociation of drugs in the body, non-active ingredients of polymer compounds, and medical preparations of non-active ingredients, etc. Control release and other issues to achieve the effect of strong penetration ability of organisms and small cell damage
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0031] Specific Embodiment 1: The preparation method of a core-shell structure drug carrier of a near-infrared light-excited supramolecular valve light-controlled drug release in this embodiment is specifically carried out according to the following steps:
[0032] 1. Synthesis of upconversion nanoparticle core: NaYF 4 : Yb / Tm up-conversion nanoparticles are dispersed in cyclohexane to obtain up-conversion nanoparticles cores;
[0033] 2. Synthesis of up-conversion nanoparticles coated with shells: adding oleic acid, octadecene and the up-conversion nanoparticles core obtained in step 1 to yttrium chloride hexahydrate to obtain a reaction system, under the conditions of argon protection and stirring The temperature of the reaction system was raised from room temperature to 160°C, and stirred for 1.5h under the protection of argon at a temperature of 160°C, then the temperature was naturally cooled from 160°C to 50°C, then the mixed solution A was added, and then Stir for 0.5h...
specific Embodiment approach 2
[0044] Specific embodiment two: the difference between this embodiment and specific embodiment one is that the volume ratio of the mass of yttrium chloride hexahydrate described in step two to oleic acid is 1mg:0.035mL. Other steps and parameters are the same as those in the first embodiment.
specific Embodiment approach 3
[0045] Specific embodiment three: this embodiment is different from specific embodiment one or two in that: the volume ratio of the mass of yttrium chloride hexahydrate described in step two to octadecene is 1mg:0.098mL. Other steps and parameters are the same as those in Embodiment 1 or 2.
PUM
Property | Measurement | Unit |
---|---|---|
diameter | aaaaa | aaaaa |
diameter | aaaaa | aaaaa |
size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com